Click here for our Investor’s Presentation.
Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product
Neutrisci Receives Additional Order for Japanese Market
NeutriSci Announces New State-of-the-Art Production and Research Facility in Las Vegas, Nevada, USA
NeutriSci: Harmonized Code Approval Received by Tabletz LLC., in Japan
NeutriSci Receieves Multi-Million Dollar Order for Japanese Market
All information is provided “as is” for informational purposes only and is not intended for trading purposes or advice. Neither NuetriSci nor any independent providers are liable for any errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.
Subscribe to Our Newsletter
By subscribing to our Newsletter you will receive NeutriSci’s press releases and news as they develop by email. We do not send direct mail, customized online advertising, and we do not share your personal information. We respect your privacy.